Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoThe cancer vaccine reduced the likelihood cancer would return or patients would die by 49% after...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 6 days agoBiotechnology analysts believe that mRNA will become the superior vaccine technology within the next...
'Pandemic proof' vaccine could beat coronaviruses we don't even know about yet
The US Sun· 1 day agoBRITISH scientists reckon they can make a vaccine for coronaviruses we do not even know about yet....
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 4 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 6 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
First cancer jab trial finds they 'weaponise immunse system to attack tumours'
The US Sun· 6 days agoA NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows. The first-ever human clinical trial of four adult patients showed ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
InvestorPlace· 5 days agoFor a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management. A February report found that in aggregate, her ...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 5 days agoLitigation and Intellectual...Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech over lipid ...